Here is a
video on the NSB website in
April 2018 of the MD Matt Liddleow saying they are at advanced preclinical stage, and they expect to be able to go into human trials in 9 months.
If you Google:
HealthKick Podcast: NSB brings new solutions to medicine’s most stubborn eye problems - the chairman at the time states on a podcast, in February 2021, that trials will begin in a
few weeks.If you have done your DD on this stock you would know that management have been deceiving shareholders with regards to timelines time and time again... I could give multiple examples of timelines being pushed out, you don't need to look hard to find them. Latest guidance from the company is as follows
Here it was at at Sep 2021
I am getting a little bit fed up - I have sent two emails to Matt with questions, with no response, and I want answers!
Do we have the right management in place? Some of my other companies achieve more in one quarter than NSB does in 4 years... The share price is exactly where it was 12 months ago, they have not been able to grow the company in one of the wildest bull markets we have ever seen. If trials do not begin soon, do we need to start looking at our options as minority shareholders to spill the board...?
don't get me wrong, management aside I am as much of a NSB bull as they come, see here
